Validated, tissue-specific library enables customisable and controllable liver-targeted gene expression with high specificity and minimal off-target activity in muscle tissue ...
Our circadian clocks play a crucial role in our health and well-being, keeping our 24-hour biological cycles in sync with ...
After facing a delayed decision deadline and a clinical hold, Regenxbio’s Hunter syndrome gene therapy has been rejected by ...
Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today ...
BioVenic is dedicated to advancing the advancement of veterinary molecular diagnostics through its comprehensive ...
Multiple Independent Molecular Signals Converge to Validate GRI-0621 as a Potential Disease-Modifying Therapy LA JOLLA, CA, Jan. 28, 2026 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or ...
Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational ...
Dr. Rob Burgess shares how Sino Biological empowers global biomedical research through precision, quality, and ...
Producing high levels of valuable medicinal compounds in plants has long been limited by the difficulty of precisely ...
Hoth Therapeutics Inc. HOTH on Tuesday revealed preclinical data from its study on glial cell-derived neurotrophic factor ...
A research team has developed the "SUPER (Synthetic Upcycling Platform for Engineering Regulators)" platform, which ...